Literature DB >> 8776768

Intracranial metastasis of renal cell carcinoma: MR imaging.

A Uchino1, K Hasuo, A Mizushima, S Matsumoto, F Mihara, M Jimi, M Takahashi, K Masuda.   

Abstract

The purpose of this study was to evaluate the magnetic resonance (MR) findings of intracranial metastatic tumors of renal cell carcinomas (RCCs). MR images of seven patients with intracranial metastases of RCCs were retrospectively reviewed. Each of the seven patients had a single lesion, including five supratentorial intraparenchymal lesions, one 4th ventricular lesion, and one pituitary lesion. Intra- and/or peritumoral flow voids were observed in five of the seven lesions. The signal intensities of the tumors were not specific. All lesions showed gadolinium enhancement, including solid (3), nearly solid (2), and ring enhancement (2). We concluded that intra- and/or peritumoral flow void is a relatively characteristic MR finding of intracranial metastases of RCCs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8776768

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  7 in total

1.  Clinical features and surgical management of four peculiar cases of intracranial metastases from renal cell carcinoma.

Authors:  Fuyou Guo; Junkuan Wang; Laijun Song; Hongwei Sun; Bo Yang; Xianzhi Liu; Shukai Wang
Journal:  Neurol Sci       Date:  2012-01-21       Impact factor: 3.307

Review 2.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 3.  Long survival in an untreated solitary choroid plexus metastasis from renal cell carcinoma: case report and review of the literature.

Authors:  Liverana Lauretti; Eduardo Fernandez; Roberto Pallini; Luca Massimi; Alessio Albanese; Luca Denaro; Giulio Maira
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

4.  Metastatic renal cell carcinoma to the pituitary presenting with hyperprolactinemia.

Authors:  S Basaria; W H Westra; H Brem; R Salvatori
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 5.  [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].

Authors:  M-A Weber; F Risse; F L Giesel; L R Schad; H-U Kauczor; M Essig
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

6.  [Noninvasive measurement of relative cerebral blood flow with the blood bolus MRI arterial spin labeling: basic physics and clinical applications].

Authors:  M-A Weber; A Kroll; M Günther; S Delorme; J Debus; F L Giesel; M Essig; H-U Kauczor; L R Schad
Journal:  Radiologe       Date:  2004-02       Impact factor: 0.635

7.  Symptomatic pituitary metastases from renal cell carcinoma.

Authors:  Thottathil Gopan; Steven A Toms; Richard A Prayson; John H Suh; Amir H Hamrahian; Robert J Weil
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.